Table 5.
Logistic Regression modelling on biomarkers and motor impairment (HY 3 or above) at 36 months follow-up
| Baseline Biomarkers | TL (T/S ratio) | p21 expression (A.U.) | p16 expression (A.U.) | Inflammatory Score | ||||||
| O.R. | p value | O.R. | p value | O.R. | p value | O.R. | p value | |||
| Motor Impairment | at 36 monthsa | 0.217 | 0.273 | 1.000 | 0.698 | 0.988 | 0.831 | 1.006 | 0.939 | |
| Change over 36 monthsb | Motor Improvement | 0.383 | 0.534 | 0.415 | 0.171 | 0.995 | 0.805 | 1.086 | 0.367 | |
| Motor Impairment | 0.535 | 0.748 | 1.000 | 0.941 | 0.471 | 0.288 | 1.110 | 0.374 | ||
O.R., Odds Ratio; aBinary Logistic Regression. bMultinomial Logistic Regression. Reference category: No Change from Baseline to 36 months follow-up; Motor Improvement: from HY≥3 to HY < 3; Motor Impairment: from HY < 3 to HY≥3. All models adjusted for age, gender, baseline LEDD and BMI.